首页 > 最新文献

Radiology最新文献

英文 中文
Highlights of the 2023 Amendments to the MQSA Implementing Regulations. 2023 年 MQSA 实施细则修正案要点。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.242203
David L Lerner

The Mammography Quality Standards Act (MQSA) of 1992 is intended to ensure that mammography practice nationwide meets consistent baseline quality standards. Amendments to the MQSA implementing regulations ("Amendments") were published on March 10, 2023, and are effective on September 10, 2024. The Amendments address various aspects of the program, including mammography technology, enforcement, the retention and transfer of personnel records and medical records, the medical outcomes audit, and mammography reporting, including (but not limited to) reporting of breast tissue density. The amended regulations are available online, and the Food and Drug Admininstration (FDA) offers several resources for mammography facilities and other stakeholders to receive additional information, including a facility hotline, a summary document distributed to all certified mammography facilities, and a Small Entity Compliance Guide (or SECG) written in question-and-answer format, which the FDA intends to be helpful to facilities of any size.

1992 年的《乳腺 X 射线摄影质量标准法案》(MQSA)旨在确保全国范围内的乳腺 X 射线摄影实践符合一致的基准质量标准。MQSA 实施条例修正案(以下简称 "修正案")于 2023 年 3 月 10 日公布,并于 2024 年 9 月 10 日生效。修正案涉及该计划的各个方面,包括乳腺 X 射线摄影技术、执行、人事记录和医疗记录的保留和转移、医疗结果审核以及乳腺 X 射线摄影报告,包括(但不限于)乳腺组织密度报告。修订后的法规可在网上查阅,食品与药物管理局 (FDA) 还为乳腺 X 射线照相机构和其他利益相关者提供了多种资源以获取更多信息,包括机构热线、分发给所有认证乳腺 X 射线照相机构的摘要文件,以及以问答形式编写的《小型实体合规指南》(或 SECG),FDA 希望该指南能对任何规模的机构有所帮助。
{"title":"Highlights of the 2023 Amendments to the MQSA Implementing Regulations.","authors":"David L Lerner","doi":"10.1148/radiol.242203","DOIUrl":"10.1148/radiol.242203","url":null,"abstract":"<p><p>The Mammography Quality Standards Act (MQSA) of 1992 is intended to ensure that mammography practice nationwide meets consistent baseline quality standards. Amendments to the MQSA implementing regulations (\"Amendments\") were published on March 10, 2023, and are effective on September 10, 2024. The Amendments address various aspects of the program, including mammography technology, enforcement, the retention and transfer of personnel records and medical records, the medical outcomes audit, and mammography reporting, including (but not limited to) reporting of breast tissue density. The amended regulations are available online, and the Food and Drug Admininstration (FDA) offers several resources for mammography facilities and other stakeholders to receive additional information, including a facility hotline, a summary document distributed to all certified mammography facilities, and a Small Entity Compliance Guide (or SECG) written in question-and-answer format, which the FDA intends to be helpful to facilities of any size.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining AI and Radiomics to Improve the Accuracy of Breast US. 将人工智能与放射组学相结合,提高乳腺 US 的准确性。
IF 19.7 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.241795
Manisha Bahl
{"title":"Combining AI and Radiomics to Improve the Accuracy of Breast US.","authors":"Manisha Bahl","doi":"10.1148/radiol.241795","DOIUrl":"https://doi.org/10.1148/radiol.241795","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":19.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142222660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease. 美国非酒精性脂肪肝剪切波和瞬态弹性成像的再现性和重复性。
IF 19.7 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.233094
Theodore T Pierce,Arinc Ozturk,Sarah P Sherlock,Guilherme Moura Cunha,Xiaohong Wang,Qian Li,David Hunt,Michael S Middleton,Marian Martin,Kathleen E Corey,Hannah Edenbaum,Sudha S Shankar,Helen Heymann,Tania N Kamphaus,Roberto A Calle,Yesenia Covarrubias,Rohit Loomba,Nancy A Obuchowski,Arun J Sanyal,Claude B Sirlin,Kathryn J Fowler,Anthony E Samir
Background US shear-wave elastography (SWE) and vibration-controlled transient elastography (VCTE) enable assessment of liver stiffness, an indicator of fibrosis severity. However, limited reproducibility data restrict their use in clinical trials. Purpose To estimate SWE and VCTE measurement variability in nonalcoholic fatty liver disease (NAFLD) within and across systems to support clinical trial diagnostic enrichment and clinical interpretation of longitudinal liver stiffness. Materials and Methods This prospective, observational, cross-sectional study (March 2021 to November 2021) enrolled adults with NAFLD, stratified according to the Fibrosis-4 (FIB-4) index (≤1.3, >1.3 and <2.67, ≥2.67), at two sites to assess SWE with five US systems and VCTE with one system. Each participant underwent 12 elastography examinations over two separate days within 1 week, with each day's examinations conducted by a different operator. VCTE and SWE measurements were reported in units of meters per second. The primary end point was the different-day, different-operator reproducibility coefficient (RDCDDDO) pooled across systems for SWE and individually for VCTE. Secondary end points included system-specific RDCDDDO, same-day, same-operator repeatability coefficient (RCSDSO), and between-system same-day, same-operator reproducibility coefficient. The planned sample provided 80% power to detect a pooled RDCDDDO of less than 35%, the prespecified performance threshold. Results A total of 40 participants (mean age, 60 years ± 10 [SD]; 24 women) with low (n = 17), intermediate (n = 15), and high (n = 8) FIB-4 scores were enrolled. RDCDDDO was 30.7% (95% upper bound, 34.4%) for SWE and 35.6% (95% upper bound, 43.9%) for VCTE. SWE system-specific RDCDDDO varied from 24.2% to 34.3%. The RCSDSO was 21.0% for SWE (range, 13.9%-35.0%) and 19.6% for VCTE. The SWE between-system same-day, same-operator reproducibility coefficient was 52.7%. Conclusion SWE met the prespecified threshold, RDCDDDO less than 35%, with VCTE having a higher RDCDDDO. SWE variability was higher between different systems. These estimates advance liver US-based noninvasive test qualification by (a) defining expected variability, (b) establishing that serial examination variability is lower when performed with the same system, and (c) informing clinical trial design. ClinicalTrials.gov Identifier NCT04828551 © RSNA, 2024 Supplemental material is available for this article.
背景 美国剪切波弹性成像(SWE)和振动控制瞬态弹性成像(VCTE)可评估肝脏硬度,这是纤维化严重程度的一个指标。然而,有限的重现性数据限制了它们在临床试验中的应用。目的 估计非酒精性脂肪肝(NAFLD)在系统内和系统间的 SWE 和 VCTE 测量变异性,以支持临床试验诊断的丰富性和纵向肝脏硬度的临床解释。材料和方法 这项前瞻性、观察性、横断面研究(2021 年 3 月至 2021 年 11 月)在两个地点招募了非酒精性脂肪肝成人患者,根据纤维化-4 (FIB-4) 指数(≤1.3,>1.3 和<2.67,≥2.67)进行分层,用五种 US 系统评估 SWE,用一种系统评估 VCTE。每位参与者在一周内分两天接受了 12 次弹性成像检查,每天的检查由不同的操作员进行。VCTE 和 SWE 测量值以米/秒为单位进行报告。主要终点是不同日期、不同操作员的可重复性系数(RDCDDDO),SWE 为不同系统的集合,VCTE 为单个系统的集合。次要终点包括系统特异性 RDCDDDO、同日同操作者重复性系数 (RCSDSO) 以及系统间同日同操作者重复性系数。计划中的样本提供了 80% 的功率来检测小于 35% 的集合 RDCDDDO,这是预设的性能阈值。结果 共有 40 名参与者(平均年龄为 60 岁 ± 10 [SD];24 名女性)参加了此次研究,他们的 FIB-4 评分分别为低分(17 人)、中分(15 人)和高分(8 人)。SWE的RDCDDDO为30.7%(95%上限,34.4%),VCTE为35.6%(95%上限,43.9%)。全部门教育系统的 RDCDDDO 从 24.2% 到 34.3% 不等。全部门教育的 RCSDSO 为 21.0%(范围为 13.9%-35.0%),非全部门教育的 RCSDSO 为 19.6%。SWE系统间同一天、同一操作者的可重复性系数为52.7%。结论 SWE 符合预设阈值,即 RDCDDDO 小于 35%,而 VCTE 的 RDCDDDO 较高。不同系统之间的 SWE 变异性更高。这些估算通过(a)定义预期变异性,(b)确定使用同一系统进行连续检查时变异性较低,以及(c)为临床试验设计提供信息,从而推动了基于美国肝脏的无创检验鉴定。ClinicalTrials.gov Identifier NCT04828551 © RSNA, 2024 本文有补充材料。
{"title":"Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.","authors":"Theodore T Pierce,Arinc Ozturk,Sarah P Sherlock,Guilherme Moura Cunha,Xiaohong Wang,Qian Li,David Hunt,Michael S Middleton,Marian Martin,Kathleen E Corey,Hannah Edenbaum,Sudha S Shankar,Helen Heymann,Tania N Kamphaus,Roberto A Calle,Yesenia Covarrubias,Rohit Loomba,Nancy A Obuchowski,Arun J Sanyal,Claude B Sirlin,Kathryn J Fowler,Anthony E Samir","doi":"10.1148/radiol.233094","DOIUrl":"https://doi.org/10.1148/radiol.233094","url":null,"abstract":"Background US shear-wave elastography (SWE) and vibration-controlled transient elastography (VCTE) enable assessment of liver stiffness, an indicator of fibrosis severity. However, limited reproducibility data restrict their use in clinical trials. Purpose To estimate SWE and VCTE measurement variability in nonalcoholic fatty liver disease (NAFLD) within and across systems to support clinical trial diagnostic enrichment and clinical interpretation of longitudinal liver stiffness. Materials and Methods This prospective, observational, cross-sectional study (March 2021 to November 2021) enrolled adults with NAFLD, stratified according to the Fibrosis-4 (FIB-4) index (≤1.3, >1.3 and <2.67, ≥2.67), at two sites to assess SWE with five US systems and VCTE with one system. Each participant underwent 12 elastography examinations over two separate days within 1 week, with each day's examinations conducted by a different operator. VCTE and SWE measurements were reported in units of meters per second. The primary end point was the different-day, different-operator reproducibility coefficient (RDCDDDO) pooled across systems for SWE and individually for VCTE. Secondary end points included system-specific RDCDDDO, same-day, same-operator repeatability coefficient (RCSDSO), and between-system same-day, same-operator reproducibility coefficient. The planned sample provided 80% power to detect a pooled RDCDDDO of less than 35%, the prespecified performance threshold. Results A total of 40 participants (mean age, 60 years ± 10 [SD]; 24 women) with low (n = 17), intermediate (n = 15), and high (n = 8) FIB-4 scores were enrolled. RDCDDDO was 30.7% (95% upper bound, 34.4%) for SWE and 35.6% (95% upper bound, 43.9%) for VCTE. SWE system-specific RDCDDDO varied from 24.2% to 34.3%. The RCSDSO was 21.0% for SWE (range, 13.9%-35.0%) and 19.6% for VCTE. The SWE between-system same-day, same-operator reproducibility coefficient was 52.7%. Conclusion SWE met the prespecified threshold, RDCDDDO less than 35%, with VCTE having a higher RDCDDDO. SWE variability was higher between different systems. These estimates advance liver US-based noninvasive test qualification by (a) defining expected variability, (b) establishing that serial examination variability is lower when performed with the same system, and (c) informing clinical trial design. ClinicalTrials.gov Identifier NCT04828551 © RSNA, 2024 Supplemental material is available for this article.","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":19.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142222661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequential Prediction of Interstitial Lung Abnormalities Using Machine Learning. 利用机器学习对肺间质异常进行连续预测
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.242020
Marianna Zagurovskaya
{"title":"Sequential Prediction of Interstitial Lung Abnormalities Using Machine Learning.","authors":"Marianna Zagurovskaya","doi":"10.1148/radiol.242020","DOIUrl":"10.1148/radiol.242020","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer. 磁共振成像预测直肠癌患者的残留病灶和预后
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.232748
Hannah Williams, Dana M Omer, Hannah M Thompson, Sabrina T Lin, Floris S Verheij, Joao Miranda, Jonathan B Yuval, James Buckley, Michael R Marco, Li-Xuan Qin, David A Dombroski, Rajendra Kedar, Aytekin Oto, Elena Korngold, Joseph C Veniero, Sunil Gandhi, Arun Krishnaraj, Minal Jagtiani, Kirk Ohanian, Dan Vu, Thomas A Hope, Sonia Lee, Ashish P Wasnik, Nikhil Madhuripan, Marc J Gollub, Julio Garcia-Aguilar

Background MRI plays a crucial role in restaging locally advanced rectal cancer treated with total neoadjuvant therapy (TNT); however, prospective studies have not evaluated its ability to accurately select patients for nonoperative management. Purpose To evaluate the ability of restaging MRI to predict oncologic outcomes and identify imaging features associated with residual disease (RD) after TNT. Materials and Methods This was a secondary analysis of the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial, which randomized participants from April 2014 to March 2020 with stages II or III rectal adenocarcinoma to undergo either induction or consolidation TNT. Participants enrolled in the OPRA trial who underwent restaging MRI were eligible for inclusion in the present study. Radiologists classified participants as having clinical complete response (cCR), near-complete clinical response (nCR), or incomplete clinical response (iCR) based on restaging MRI at a mean of 8 weeks ± 4 (SD) after treatment. Oncologic outcomes according to MRI response category were assessed using Kaplan-Meier curves. Logistic regression analysis was performed to identify imaging characteristics associated with RD. Results A total of 277 participants (median age, 58 years [IQR, 17 years]; 179 male) who were randomized in the OPRA trial had restaging MRI forms completed. The median follow-up duration was 4.1 years. Participants with cCR had higher rates of organ preservation compared with those with nCR (65.3% vs 41.6%, log-rank P < .001). Five-year disease-free survival for participants with cCR, nCR, and iCR was 81.8%, 67.6%, and 49.6%, respectively (log-rank P < .001). The MRI response category also predicted overall survival (log-rank P < .001), distant recurrence-free survival (log-rank P = .005), and local regrowth (log-rank P = .02). Among the 266 participants with at least 2 years of follow-up, 129 (48.5%) had RD. At multivariable analysis, the presence of restricted diffusion (odds ratio, 2.50; 95% CI: 1.22, 5.24) and abnormal nodal morphologic features (odds ratio, 5.04; 95% CI: 1.43, 23.9) remained independently associated with RD. Conclusion The MRI response category was predictive of organ preservation and survival. Restricted diffusion and abnormal nodal morphologic features on restaging MRI scans were associated with increased likelihood of residual tumor. ClinicalTrials.gov identifier: NCT02008656 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Milot in this issue.

背景 MRI 在对接受全新药辅助治疗 (TNT) 的局部晚期直肠癌进行重新分期方面发挥着重要作用;然而,前瞻性研究尚未评估其准确选择患者接受非手术治疗的能力。目的 评估 MRI 重分期预测肿瘤预后的能力,并确定与 TNT 后残留疾病(RD)相关的影像学特征。材料与方法 这是直肠腺癌器官保留(OPRA)试验的一项二次分析,该试验在 2014 年 4 月至 2020 年 3 月期间对 II 期或 III 期直肠腺癌患者进行随机分组,让他们接受诱导或巩固 TNT 治疗。参加 OPRA 试验并接受磁共振成像重分期的参与者符合纳入本研究的条件。根据治疗后平均 8 周 ± 4 (SD) 的磁共振成像重分期结果,放射科医生将参与者分为临床完全应答 (cCR)、临床接近完全应答 (nCR) 或临床不完全应答 (iCR)。使用卡普兰-梅耶曲线评估根据磁共振成像反应类别得出的肿瘤学结果。进行逻辑回归分析以确定与RD相关的影像学特征。结果 在 OPRA 试验中,共有 277 名随机参与者(中位年龄 58 岁 [IQR,17 岁];179 名男性)填写了 MRI 重分期表。中位随访时间为 4.1 年。与nCR患者相比,cCR患者的器官保留率更高(65.3% vs 41.6%,log-rank P < .001)。cCR、nCR和iCR患者的五年无病生存率分别为81.8%、67.6%和49.6%(对数秩P < .001)。MRI 反应类别还能预测总生存率(对数秩 P < .001)、无远处复发生存率(对数秩 P = .005)和局部再生率(对数秩 P = .02)。在随访至少 2 年的 266 名参与者中,129 人(48.5%)患有 RD。在多变量分析中,弥散受限(几率比为 2.50;95% CI:1.22, 5.24)和结节形态特征异常(几率比为 5.04;95% CI:1.43, 23.9)仍与 RD 独立相关。结论 MRI 反应类别可预测器官保存和生存率。重新分期的 MRI 扫描中弥散受限和结节形态特征异常与肿瘤残留可能性增加有关。ClinicalTrials.gov 标识符:NCT02008656 © RSNA, 2024 本文有补充材料。另请参阅本期Milot的社论。
{"title":"MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.","authors":"Hannah Williams, Dana M Omer, Hannah M Thompson, Sabrina T Lin, Floris S Verheij, Joao Miranda, Jonathan B Yuval, James Buckley, Michael R Marco, Li-Xuan Qin, David A Dombroski, Rajendra Kedar, Aytekin Oto, Elena Korngold, Joseph C Veniero, Sunil Gandhi, Arun Krishnaraj, Minal Jagtiani, Kirk Ohanian, Dan Vu, Thomas A Hope, Sonia Lee, Ashish P Wasnik, Nikhil Madhuripan, Marc J Gollub, Julio Garcia-Aguilar","doi":"10.1148/radiol.232748","DOIUrl":"10.1148/radiol.232748","url":null,"abstract":"<p><p>Background MRI plays a crucial role in restaging locally advanced rectal cancer treated with total neoadjuvant therapy (TNT); however, prospective studies have not evaluated its ability to accurately select patients for nonoperative management. Purpose To evaluate the ability of restaging MRI to predict oncologic outcomes and identify imaging features associated with residual disease (RD) after TNT. Materials and Methods This was a secondary analysis of the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial, which randomized participants from April 2014 to March 2020 with stages II or III rectal adenocarcinoma to undergo either induction or consolidation TNT. Participants enrolled in the OPRA trial who underwent restaging MRI were eligible for inclusion in the present study. Radiologists classified participants as having clinical complete response (cCR), near-complete clinical response (nCR), or incomplete clinical response (iCR) based on restaging MRI at a mean of 8 weeks ± 4 (SD) after treatment. Oncologic outcomes according to MRI response category were assessed using Kaplan-Meier curves. Logistic regression analysis was performed to identify imaging characteristics associated with RD. Results A total of 277 participants (median age, 58 years [IQR, 17 years]; 179 male) who were randomized in the OPRA trial had restaging MRI forms completed. The median follow-up duration was 4.1 years. Participants with cCR had higher rates of organ preservation compared with those with nCR (65.3% vs 41.6%, log-rank <i>P</i> < .001). Five-year disease-free survival for participants with cCR, nCR, and iCR was 81.8%, 67.6%, and 49.6%, respectively (log-rank <i>P</i> < .001). The MRI response category also predicted overall survival (log-rank <i>P</i> < .001), distant recurrence-free survival (log-rank <i>P</i> = .005), and local regrowth (log-rank <i>P</i> = .02). Among the 266 participants with at least 2 years of follow-up, 129 (48.5%) had RD. At multivariable analysis, the presence of restricted diffusion (odds ratio, 2.50; 95% CI: 1.22, 5.24) and abnormal nodal morphologic features (odds ratio, 5.04; 95% CI: 1.43, 23.9) remained independently associated with RD. Conclusion The MRI response category was predictive of organ preservation and survival. Restricted diffusion and abnormal nodal morphologic features on restaging MRI scans were associated with increased likelihood of residual tumor. ClinicalTrials.gov identifier: NCT02008656 © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Milot in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of GPT-4 with Vision on Text- and Image-based ACR Diagnostic Radiology In-Training Examination Questions. 在基于文字和图像的 ACR 放射诊断学内训考试问题上,GPT-4 与视觉的表现。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.240153
Nolan Hayden, Spencer Gilbert, Laila M Poisson, Brent Griffith, Chad Klochko

Background Recent advancements, including image processing capabilities, present new potential applications of large language models such as ChatGPT (OpenAI), a generative pretrained transformer, in radiology. However, baseline performance of ChatGPT in radiology-related tasks is understudied. Purpose To evaluate the performance of GPT-4 with vision (GPT-4V) on radiology in-training examination questions, including those with images, to gauge the model's baseline knowledge in radiology. Materials and Methods In this prospective study, conducted between September 2023 and March 2024, the September 2023 release of GPT-4V was assessed using 386 retired questions (189 image-based and 197 text-only questions) from the American College of Radiology Diagnostic Radiology In-Training Examinations. Nine question pairs were identified as duplicates; only the first instance of each duplicate was considered in ChatGPT's assessment. A subanalysis assessed the impact of different zero-shot prompts on performance. Statistical analysis included χ2 tests of independence to ascertain whether the performance of GPT-4V varied between question types or subspecialty. The McNemar test was used to evaluate performance differences between the prompts, with Benjamin-Hochberg adjustment of the P values conducted to control the false discovery rate (FDR). A P value threshold of less than.05 denoted statistical significance. Results GPT-4V correctly answered 246 (65.3%) of the 377 unique questions, with significantly higher accuracy on text-only questions (81.5%, 159 of 195) than on image-based questions (47.8%, 87 of 182) (χ2 test, P < .001). Subanalysis revealed differences between prompts on text-based questions, where chain-of-thought prompting outperformed long instruction by 6.1% (McNemar, P = .02; FDR = 0.063), basic prompting by 6.8% (P = .009, FDR = 0.044), and the original prompting style by 8.9% (P = .001, FDR = 0.014). No differences were observed between prompts on image-based questions with P values of .27 to >.99. Conclusion While GPT-4V demonstrated a level of competence in text-based questions, it showed deficits interpreting radiologic images. © RSNA, 2024 See also the editorial by Deng in this issue.

背景 最近的进步(包括图像处理能力)为大型语言模型(如 ChatGPT (OpenAI),一种生成式预训练转换器)在放射学中的应用提供了新的潜力。然而,ChatGPT 在放射学相关任务中的基线性能还未得到充分研究。目的 评估带视觉的 GPT-4 (GPT-4V)在放射学内训考题(包括带图像的考题)中的表现,以衡量模型在放射学方面的基线知识。材料与方法 在这项于 2023 年 9 月至 2024 年 3 月期间进行的前瞻性研究中,使用美国放射学会放射诊断学内训考试中的 386 道退役试题(189 道基于图像的试题和 197 道纯文字试题)对 2023 年 9 月发布的 GPT-4V 进行了评估。有九个问题对被认定为重复问题;在 ChatGPT 的评估中只考虑了每个重复问题的第一个实例。一项子分析评估了不同的零枪提示对成绩的影响。统计分析包括χ2独立性检验,以确定GPT-4V的成绩是否因问题类型或亚专业而异。McNemar 检验用于评估不同提示语之间的成绩差异,并对 P 值进行 Benjamin-Hochberg 调整以控制误发现率 (FDR)。P 值小于 0.05 的临界值表示统计显著性。结果 GPT-4V 正确回答了 377 个独特问题中的 246 个(65.3%),纯文本问题(81.5%,195 个问题中的 159 个)的正确率明显高于图像问题(47.8%,182 个问题中的 87 个)(χ2 检验,P < .001)。子分析表明,文字类问题的提示方式之间存在差异,其中思维链提示方式比长提示方式高出 6.1%(McNemar,P = .02;FDR = 0.063),比基本提示方式高出 6.8%(P = .009,FDR = 0.044),比原始提示方式高出 8.9%(P = .001,FDR = 0.014)。在图像类问题上,不同提示方式之间没有发现差异,P 值从 .27 到 >.99。结论 虽然 GPT-4V 在基于文本的问题上表现出了一定的能力水平,但在解读放射图像方面却存在缺陷。RSNA, 2024 另请参阅本期 Deng 的社论。
{"title":"Performance of GPT-4 with Vision on Text- and Image-based ACR Diagnostic Radiology In-Training Examination Questions.","authors":"Nolan Hayden, Spencer Gilbert, Laila M Poisson, Brent Griffith, Chad Klochko","doi":"10.1148/radiol.240153","DOIUrl":"10.1148/radiol.240153","url":null,"abstract":"<p><p>Background Recent advancements, including image processing capabilities, present new potential applications of large language models such as ChatGPT (OpenAI), a generative pretrained transformer, in radiology. However, baseline performance of ChatGPT in radiology-related tasks is understudied. Purpose To evaluate the performance of GPT-4 with vision (GPT-4V) on radiology in-training examination questions, including those with images, to gauge the model's baseline knowledge in radiology. Materials and Methods In this prospective study, conducted between September 2023 and March 2024, the September 2023 release of GPT-4V was assessed using 386 retired questions (189 image-based and 197 text-only questions) from the American College of Radiology Diagnostic Radiology In-Training Examinations. Nine question pairs were identified as duplicates; only the first instance of each duplicate was considered in ChatGPT's assessment. A subanalysis assessed the impact of different zero-shot prompts on performance. Statistical analysis included χ<sup>2</sup> tests of independence to ascertain whether the performance of GPT-4V varied between question types or subspecialty. The McNemar test was used to evaluate performance differences between the prompts, with Benjamin-Hochberg adjustment of the <i>P</i> values conducted to control the false discovery rate (FDR). A <i>P</i> value threshold of less than.05 denoted statistical significance. Results GPT-4V correctly answered 246 (65.3%) of the 377 unique questions, with significantly higher accuracy on text-only questions (81.5%, 159 of 195) than on image-based questions (47.8%, 87 of 182) (χ<sup>2</sup> test, <i>P</i> < .001). Subanalysis revealed differences between prompts on text-based questions, where chain-of-thought prompting outperformed long instruction by 6.1% (McNemar, <i>P</i> = .02; FDR = 0.063), basic prompting by 6.8% (<i>P</i> = .009, FDR = 0.044), and the original prompting style by 8.9% (<i>P</i> = .001, FDR = 0.014). No differences were observed between prompts on image-based questions with <i>P</i> values of .27 to >.99. Conclusion While GPT-4V demonstrated a level of competence in text-based questions, it showed deficits interpreting radiologic images. © RSNA, 2024 See also the editorial by Deng in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer. 用于评估膀胱癌肌肉侵犯的对比增强 US VI-RADS 的开发与验证
IF 19.7 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.232815
Jing Han,Min Lin,Qingguang Lin,Ruohan Guo,Ying Liao,Zhiming Wu,Yunlin Ye,Zhixing Guo,Kai Yao,Lingling Li,Jianhua Zhou
Background Contrast-enhanced US (CEUS) can be used preoperatively for evaluating muscle invasion in bladder cancer, which is important for determining appropriate treatment. However, diagnostic criteria for assessing this at CEUS have not been standardized. Purpose To develop and validate a CEUS Vesical Imaging Reporting and Data System (VI-RADS) for evaluating muscle invasion in bladder cancer. Materials and Methods This single-center prospective study consecutively enrolled patients with suspected bladder cancer. Participants underwent transabdominal or intracavity CEUS between July 2021 and May 2023. Participants were divided into a training set and a validation set at a 2:1 ratio based on the chronologic order of enrollment. The training set was used to identify major imaging features to include in CEUS VI-RADS, and the likelihood of muscle invasion per category was determined using a pathologic reference standard. The optimal VI-RADS category cutoff for muscle invasion was determined with use of the maximum Youden index. The validation set was assessed by novice and expert readers and used to validate the diagnostic performance and interreader agreement of the developed system. Results Overall, 126 participants (median age, 64 years [IQR, 57-71 years]; 107 male) and 67 participants (median age, 64 years [IQR, 56-69 years]; 49 male) were included in the training and validation set, respectively. In the training set, the optimal CEUS VI-RADS category cutoff for muscle invasion was VI-RADS 4 or higher (Youden index, 0.77). In the validation set, CEUS VI-RADS achieved good performance for both novice and expert readers (area under the receiver operating characteristic curve, 0.80 [95% CI: 0.70, 0.90] vs 0.88 [95% CI: 0.80, 0.97]; P = .09). The interreader agreement regarding the evaluation of CEUS VI-RADS category was 0.77 (95% CI: 0.65, 0.85) for novice readers, 0.87 (95% CI: 0.79, 0.92) for expert readers, and 0.78 (95% CI: 0.70, 0.84) for all readers. Conclusion The developed CEUS VI-RADS showed good performance and interreader agreement for the assessment of muscle invasion in bladder cancer. Chinese Clinical Trial Registry no. ChiCTR2100049435 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Morrell in this issue.
背景 对比增强 US(CEUS)可用于术前评估膀胱癌的肌肉侵犯情况,这对确定适当的治疗非常重要。然而,CEUS 评估肌肉侵犯的诊断标准尚未标准化。目的 开发并验证用于评估膀胱癌肌肉侵犯的 CEUS 膀胱成像报告和数据系统 (VI-RADS)。材料和方法 这项单中心前瞻性研究连续招募疑似膀胱癌患者。参与者在 2021 年 7 月至 2023 年 5 月期间接受了经腹或腔内 CEUS 检查。根据入组的时间顺序,以 2:1 的比例将参与者分为训练集和验证集。训练集用于确定CEUS VI-RADS中应包含的主要成像特征,并使用病理学参考标准确定每个类别中肌肉受侵的可能性。使用最大尤登指数确定肌肉侵犯的最佳VI-RADS类别截止值。验证集由新手和专家阅读者进行评估,用于验证所开发系统的诊断性能和阅读者之间的一致性。结果 共有 126 名参与者(中位年龄 64 岁 [IQR,57-71 岁];107 名男性)和 67 名参与者(中位年龄 64 岁 [IQR,56-69 岁];49 名男性)分别被纳入训练集和验证集。在训练集中,肌肉侵犯的最佳 CEUS VI-RADS 类别临界值为 VI-RADS 4 或更高(尤登指数,0.77)。在验证集中,CEUS VI-RADS 对新手和专家读者都有良好的表现(接收者操作特征曲线下面积,0.80 [95% CI: 0.70, 0.90] vs 0.88 [95% CI: 0.80, 0.97]; P = .09)。对于 CEUS VI-RADS 类别的评估,新手读者的读数一致性为 0.77(95% CI:0.65,0.85),专家读者为 0.87(95% CI:0.79,0.92),所有读者均为 0.78(95% CI:0.70,0.84)。结论 所开发的 CEUS VI-RADS 在评估膀胱癌肌肉侵犯方面表现出良好的性能和读片者之间的一致性。中国临床试验注册中心编号ChiCTR2100049435 © RSNA, 2024 本文有补充材料。另请参阅本期莫雷尔的社论。
{"title":"Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer.","authors":"Jing Han,Min Lin,Qingguang Lin,Ruohan Guo,Ying Liao,Zhiming Wu,Yunlin Ye,Zhixing Guo,Kai Yao,Lingling Li,Jianhua Zhou","doi":"10.1148/radiol.232815","DOIUrl":"https://doi.org/10.1148/radiol.232815","url":null,"abstract":"Background Contrast-enhanced US (CEUS) can be used preoperatively for evaluating muscle invasion in bladder cancer, which is important for determining appropriate treatment. However, diagnostic criteria for assessing this at CEUS have not been standardized. Purpose To develop and validate a CEUS Vesical Imaging Reporting and Data System (VI-RADS) for evaluating muscle invasion in bladder cancer. Materials and Methods This single-center prospective study consecutively enrolled patients with suspected bladder cancer. Participants underwent transabdominal or intracavity CEUS between July 2021 and May 2023. Participants were divided into a training set and a validation set at a 2:1 ratio based on the chronologic order of enrollment. The training set was used to identify major imaging features to include in CEUS VI-RADS, and the likelihood of muscle invasion per category was determined using a pathologic reference standard. The optimal VI-RADS category cutoff for muscle invasion was determined with use of the maximum Youden index. The validation set was assessed by novice and expert readers and used to validate the diagnostic performance and interreader agreement of the developed system. Results Overall, 126 participants (median age, 64 years [IQR, 57-71 years]; 107 male) and 67 participants (median age, 64 years [IQR, 56-69 years]; 49 male) were included in the training and validation set, respectively. In the training set, the optimal CEUS VI-RADS category cutoff for muscle invasion was VI-RADS 4 or higher (Youden index, 0.77). In the validation set, CEUS VI-RADS achieved good performance for both novice and expert readers (area under the receiver operating characteristic curve, 0.80 [95% CI: 0.70, 0.90] vs 0.88 [95% CI: 0.80, 0.97]; P = .09). The interreader agreement regarding the evaluation of CEUS VI-RADS category was 0.77 (95% CI: 0.65, 0.85) for novice readers, 0.87 (95% CI: 0.79, 0.92) for expert readers, and 0.78 (95% CI: 0.70, 0.84) for all readers. Conclusion The developed CEUS VI-RADS showed good performance and interreader agreement for the assessment of muscle invasion in bladder cancer. Chinese Clinical Trial Registry no. ChiCTR2100049435 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Morrell in this issue.","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":19.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142222670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Echoes to Disruption: US from Diagnostic Imaging to Precision Therapeutic Modality. 从回声到破坏:US 从诊断成像到精准治疗模式。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.242012
Nariman Nezami, Christos Georgiades
{"title":"From Echoes to Disruption: US from Diagnostic Imaging to Precision Therapeutic Modality.","authors":"Nariman Nezami, Christos Georgiades","doi":"10.1148/radiol.242012","DOIUrl":"10.1148/radiol.242012","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amplifying Research: The Potential for Podcasts to Boost Radiology Journal Article Exposure. 放大研究:播客提高放射学期刊论文曝光率的潜力》。
IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.233057
Mark Wang, Thuy Le, David A Leswick

Background Podcasts have become an increasingly popular method of communicating information in medicine, including in radiology. However, the effect of podcasts on the reach of journal articles remains unclear. Purpose To evaluate the influence of Radiology podcasts on the performance metrics, including downloads, citations, and Altmetric Attention Score (AAS), of Radiology articles. Materials and Methods This was a retrospective study. All articles published in the print version of Radiology from January 2021 to December 2022 were reviewed; editorials and case reports were excluded. Articles featured on Radiology podcasts were included in the podcast group. Articles published within the same journal issue and category were the nonpodcast group. Downloads, Google Scholar citations, Dimensions citations, and AAS metrics were recorded. The Mann-Whitney U test was used to compare medians and evaluate differences between older and more recently published articles. Results The podcast group, composed of 88 articles, exhibited significantly higher median values for downloads (PG, 4521.0; nonpodcast group, 2123.0; P < .001), Google Scholar citations (podcast group, 14.5; nonpodcast group, 10.0; P = .01), Dimensions citations (podcast group, 12.0; nonpodcast group, 9.0; P = .01), and AAS (podcast group, 43.0; nonpodcast group, 10.0; P < .001) compared with the nonpodcast group of 378 articles. Within both groups, articles published in the earlier nonpodcast group (January to June 2021) had higher downloads (podcast group, P = .08; nonpodcast group, P < .001), Google Scholar citations (podcast group and nonpodcast group, P < .001), and Dimension citations (podcast group and nonpodcast group, P < .001) than articles from the later period (July to December 2022). AAS markedly increased in recent podcast articles (P = .03), but AAS for nonpodcast articles significantly decreased over time (P = .01). Conclusion Radiology articles featured on the Radiology podcast had greater median metrics, including downloads, Google Scholar citations, Dimensions citations, and AAS, compared with nonpodcast articles, suggesting that podcasts can be an effective method of disseminating and amplifying research within the field of radiology. © RSNA, 2024 See also the editorial by Chu and Nicola in this issue.

背景 播客已成为包括放射学在内的医学领域越来越流行的信息传播方式。然而,播客对期刊论文传播范围的影响仍不清楚。目的 评估《放射学》播客对《放射学》文章的性能指标(包括下载量、引用率和 Altmetric Attention Score (AAS))的影响。材料与方法 这是一项回顾性研究。研究人员审阅了2021年1月至2022年12月期间在《放射学》印刷版上发表的所有文章;社论和病例报告不在此列。在《放射学》播客上发表的文章被纳入播客组。在同一期刊刊号和类别中发表的文章为非播客组别。记录下载量、Google Scholar引用率、Dimensions引用率和AAS指标。采用曼-惠特尼 U 检验比较中位数,并评估较早和较新发表文章之间的差异。结果 由 88 篇文章组成的播客组在下载量(PG,4521.0;非播客组,2123.0;P < .001)、谷歌学术引用率(播客组,14.5; nonpodcast group, 10.0; P = .01), Dimensions citations (podcast group, 12.0; nonpodcast group, 9.0; P = .01), and AAS (podcast group, 43.0; nonpodcast group, 10.0; P < .001) compared with the nonodcast group of 378 articles.在这两组中,较早的非播客组中(2021年1月至6月)发表的文章的下载量(播客组,P = .08;非播客组,P < .001)、谷歌学术引用率(播客组和非播客组,P < .001)和维度引用率(播客组和非播客组,P < .001)均高于较晚时期(2022年7月至12月)的文章。近期播客文章的AAS显著增加(P = .03),但非播客文章的AAS随时间推移显著下降(P = .01)。结论 与非播客文章相比,在《放射学》播客上发表的放射学文章具有更高的中值指标,包括下载量、谷歌学术引用率、维度引用率和AAS,这表明播客是传播和扩大放射学领域研究的有效方法。© RSNA, 2024 另请参阅本期 Chu 和 Nicola 的社论。
{"title":"Amplifying Research: The Potential for Podcasts to Boost <i>Radiology</i> Journal Article Exposure.","authors":"Mark Wang, Thuy Le, David A Leswick","doi":"10.1148/radiol.233057","DOIUrl":"10.1148/radiol.233057","url":null,"abstract":"<p><p>Background Podcasts have become an increasingly popular method of communicating information in medicine, including in radiology. However, the effect of podcasts on the reach of journal articles remains unclear. Purpose To evaluate the influence of <i>Radiology</i> podcasts on the performance metrics, including downloads, citations, and Altmetric Attention Score (AAS), of <i>Radiology</i> articles. Materials and Methods This was a retrospective study. All articles published in the print version of <i>Radiology</i> from January 2021 to December 2022 were reviewed; editorials and case reports were excluded. Articles featured on <i>Radiology</i> podcasts were included in the podcast group. Articles published within the same journal issue and category were the nonpodcast group. Downloads, Google Scholar citations, Dimensions citations, and AAS metrics were recorded. The Mann-Whitney <i>U</i> test was used to compare medians and evaluate differences between older and more recently published articles. Results The podcast group, composed of 88 articles, exhibited significantly higher median values for downloads (PG, 4521.0; nonpodcast group, 2123.0; <i>P</i> < .001), Google Scholar citations (podcast group, 14.5; nonpodcast group, 10.0; <i>P</i> = .01), Dimensions citations (podcast group, 12.0; nonpodcast group, 9.0; <i>P</i> = .01), and AAS (podcast group, 43.0; nonpodcast group, 10.0; <i>P</i> < .001) compared with the nonpodcast group of 378 articles. Within both groups, articles published in the earlier nonpodcast group (January to June 2021) had higher downloads (podcast group, <i>P</i> = .08; nonpodcast group, <i>P</i> < .001), Google Scholar citations (podcast group and nonpodcast group, <i>P</i> < .001), and Dimension citations (podcast group and nonpodcast group, <i>P</i> < .001) than articles from the later period (July to December 2022). AAS markedly increased in recent podcast articles (<i>P</i> = .03), but AAS for nonpodcast articles significantly decreased over time (<i>P</i> = .01). Conclusion <i>Radiology</i> articles featured on the <i>Radiology</i> podcast had greater median metrics, including downloads, Google Scholar citations, Dimensions citations, and AAS, compared with nonpodcast articles, suggesting that podcasts can be an effective method of disseminating and amplifying research within the field of radiology. © RSNA, 2024 See also the editorial by Chu and Nicola in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":12.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer. 核磁共振成像引导下的前列腺癌聚焦超声病灶疗法的基本原理。
IF 19.7 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2024-09-01 DOI: 10.1148/radiol.240738
Takeshi Takahashi
{"title":"Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer.","authors":"Takeshi Takahashi","doi":"10.1148/radiol.240738","DOIUrl":"https://doi.org/10.1148/radiol.240738","url":null,"abstract":"","PeriodicalId":20896,"journal":{"name":"Radiology","volume":null,"pages":null},"PeriodicalIF":19.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142222662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1